BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28061034)

  • 1. Delayed Diagnosis of a Nasal Type Lymphoma Misdiagnosed as Persistent Sinusitis.
    Celentano A; Mascolo M; Cirillo N; De Rosa G; Mignogna MD
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):381-384. PubMed ID: 28061034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Oh D; Ahn YC; Kim SJ; Kim WS; Ko YH
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):677-83. PubMed ID: 26461010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008).
    Yoon DH; Kim SJ; Jeong SH; Shin DY; Bae SH; Hong J; Park SK; Yhim HY; Yang DH; Lee H; Kang HJ; Lee MH; Eom HS; Kwak JY; Lee JH; Suh C; Kim WS
    Oncotarget; 2016 Dec; 7(51):85584-85591. PubMed ID: 27542213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nasal NK/T-cell lymphoma: about two rare cases].
    Bouayad N; Oubelkacem N; Bono W; Masbah O; Bouhafa T; Elmazghi A; Khalid H
    Pan Afr Med J; 2018; 30():141. PubMed ID: 30374387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.
    Yamaguchi M; Suzuki R; Kwong YL; Kim WS; Hasegawa Y; Izutsu K; Suzumiya J; Okamura T; Nakamura S; Kawa K; Oshimi K
    Cancer Sci; 2008 May; 99(5):1016-20. PubMed ID: 18294294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
    Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant.
    Inoue D; Nagai Y; Takiuchi Y; Nagano S; Arima H; Kimura T; Shimoji S; Mori M; Togami K; Tabata S; Yanagita S; Matsushita A; Nagai K; Maruoka H; Imai Y; Suzuki R; Takahashi T
    Leuk Lymphoma; 2010 Apr; 51(4):720-3. PubMed ID: 20233057
    [No Abstract]   [Full Text] [Related]  

  • 8. Extranodal NK/T cell lymphoma, nasal type, presenting with meningeal infiltration in a Caucasian female.
    Hildyard C; Sheikh S; Eyre T; Collins G
    Br J Haematol; 2013 Dec; 163(5):550. PubMed ID: 24033120
    [No Abstract]   [Full Text] [Related]  

  • 9. Extranodal sinonasal natural killer/T-cell lymphoma presenting as chronic sinusitis and necrotic wound infection.
    Karaman E; Yilmaz M; Alimoglu Y; Edizer DT; Isildak H; Ozek H
    J Craniofac Surg; 2009 Nov; 20(6):2095-6. PubMed ID: 19881363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinonasal NK/T-cell lymphoma.
    Hmidi M; Kettani M; Elboukhari A; Touiheme N; Messary A
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):145-7. PubMed ID: 23273887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal Type Extranodal Natural Killer/T (NK/T) Cell Lymphoma Presenting as Periorbital Cellulitis: A Case Report.
    Al Shawabkeh MA; Al Sulaiti M; Al Sa'ey H; Ganesan S
    Am J Case Rep; 2016 Dec; 17():934-938. PubMed ID: 27932776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Extra-nodal NK/T-cell lymphoma, nasal type presenting as orbital cellulitis].
    Amri GE; Zalagh M; Benariba F
    Pan Afr Med J; 2018; 31():8. PubMed ID: 30918537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of brainstem involvement in NK/T cell lymphoma.
    So JC; Chan KH; Pang AW; Chan JK; Kwong YL
    Ann Hematol; 2014 Aug; 93(8):1433-4. PubMed ID: 24292537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary colonic extranasal NK/T-cell lymphoma: about a case].
    Fares S; Lamchahab M; Aniba M; Lembarki G; Mousalli N; Regragui M; Karkouri M; Quessar A
    Pan Afr Med J; 2017; 26():112. PubMed ID: 28533835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
    Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Suzuki R
    Int J Hematol; 2010 Dec; 92(5):697-701. PubMed ID: 21116747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
    Liang R; Gao GX; Chen JP; Wang JS; Wang XM; Zeng Y; Bai QX; Zhang T; Yang L; Dong BX; Gu HT; Shu MM; Hao CX; Wang JH; Zhang N; Chen XQ
    Hematol Oncol; 2017 Dec; 35(4):619-629. PubMed ID: 27723108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-asparaginase-based regimens followed by allogeneic hematopoietic stem cell transplantation improve outcomes in aggressive natural killer cell leukemia.
    Jung KS; Cho SH; Kim SJ; Ko YH; Kang ES; Kim WS
    J Hematol Oncol; 2016 Apr; 9():41. PubMed ID: 27091029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of pegaspargase in extra nodal natural killer/T-cell lymphoma nasal type: A case report from China.
    Xiong X; Cai Z; Yang J; Shu X
    J Cancer Res Ther; 2015; 11(3):665. PubMed ID: 26458696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.